Risk of Posterior Capsule Ruptures in Fellow-Eye Cataract Surgeries: A Multicenter Comparative Study.

IF 1.9 4区医学 Q2 OPHTHALMOLOGY

Seminars in Ophthalmology Pub Date : 2024-10-01 DOI:10.1080/08820538.2024.2409154

Abdelrahman M Elhusseiny, Joseph Toma, S Nazem Ibrahim, Muhammad Z Chauhan, Kaersti L Rickels, Qais Dihan, Mohamed K Soliman, Yit C Yang, Ahmed B Sallam

{"title":"Risk of Posterior Capsule Ruptures in Fellow-Eye Cataract Surgeries: A Multicenter Comparative Study.","authors":"Abdelrahman M Elhusseiny, Joseph Toma, S Nazem Ibrahim, Muhammad Z Chauhan, Kaersti L Rickels, Qais Dihan, Mohamed K Soliman, Yit C Yang, Ahmed B Sallam","doi":"10.1080/08820538.2024.2409154","DOIUrl":null,"url":null,"abstract":"Purpose: To quantify the risk of posterior capsule rupture (PCR) in fellow-eye phacoemulsification surgery and to determine risk factors.Methods: We pooled data from 8 United Kingdom sites for patients undergoing bilateral non-simultaneous phacoemulsification. Main outcome measures were the incidence and risk factors of the development of PCR during the fellow-eye phacoemulsification.Results: We included 66,288 patients with a mean age of 75.3 ± 10.2 years. PCR during phacoemulsification occurred in the first eye in 932 patients (1.4%) and the fellow eye in 1039 patients (1.5%). The risk of fellow eye developing PCR in patients with PCR in the first eye was significantly higher than in patients without first eye PCR: 30 patients (3.2%) vs. 1009 (1.5%), respectively (odds ratio (OR) = 1.7, 95% confidence interval (CI) = 1.1-2.7). Other risk factors for fellow-eye PCR included zonular dialysis (OR = 5.4, CI = 3.3-7.8) and advanced cataract (OR = 2.8, CI = 2.1-3.7).Conclusions: History of PCR in the first-operated eye is an independent risk factor for PCR in the fellow eye.","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-6"},"PeriodicalIF":1.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08820538.2024.2409154","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To quantify the risk of posterior capsule rupture (PCR) in fellow-eye phacoemulsification surgery and to determine risk factors.

Methods: We pooled data from 8 United Kingdom sites for patients undergoing bilateral non-simultaneous phacoemulsification. Main outcome measures were the incidence and risk factors of the development of PCR during the fellow-eye phacoemulsification.

Results: We included 66,288 patients with a mean age of 75.3 ± 10.2 years. PCR during phacoemulsification occurred in the first eye in 932 patients (1.4%) and the fellow eye in 1039 patients (1.5%). The risk of fellow eye developing PCR in patients with PCR in the first eye was significantly higher than in patients without first eye PCR: 30 patients (3.2%) vs. 1009 (1.5%), respectively (odds ratio (OR) = 1.7, 95% confidence interval (CI) = 1.1-2.7). Other risk factors for fellow-eye PCR included zonular dialysis (OR = 5.4, CI = 3.3-7.8) and advanced cataract (OR = 2.8, CI = 2.1-3.7).

Conclusions: History of PCR in the first-operated eye is an independent risk factor for PCR in the fellow eye.

查看原文本刊更多论文

同眼白内障手术中后囊破裂的风险：一项多中心比较研究

目的：量化同眼超声乳化手术中后囊破裂（PCR）的风险，并确定风险因素：我们汇集了来自英国 8 个研究机构的数据，这些数据均来自接受双侧非同期超声乳化手术的患者。主要结果指标为同眼乳化手术中 PCR 的发生率和风险因素：我们共纳入了 66288 名患者，平均年龄为（75.3 ± 10.2）岁。932名患者（1.4%）的第一只眼和1039名患者（1.5%）的同眼在乳化过程中发生了PCR。首眼发生 PCR 的患者同眼发生 PCR 的风险明显高于首眼未发生 PCR 的患者：分别为 30 名患者（3.2%）和 1009 名患者（1.5%）（几率比（OR）= 1.7，95% 置信区间（CI）= 1.1-2.7）。同眼 PCR 的其他风险因素包括宗性透析（OR = 5.4，CI = 3.3-7.8）和晚期白内障（OR = 2.8，CI = 2.1-3.7）：结论：第一只手术眼的 PCR 病史是导致同侧眼 PCR 的独立风险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in Ophthalmology OPHTHALMOLOGY-

CiteScore

3.20

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Seminars in Ophthalmology offers current, clinically oriented reviews on the diagnosis and treatment of ophthalmic disorders. Each issue focuses on a single topic, with a primary emphasis on appropriate surgical techniques.